Literature DB >> 7893098

Mesh between the oblique muscles is simple and effective in open hernioplasty.

A G Shulman1, P K Amid, I L Lichtenstein.   

Abstract

Controversy exists as to the best position for insertion of the mesh patch in open inguinal herniorrhaphy. The "inlay" mesh graft, which is laid under the transversalis fascia, has been considered preferable by some authors. But in the Lichtenstein open tension-free inguinal hernia repair, the mesh is preferably placed under the external oblique aponeurosis. It is not an "onlay graft" because it lies under the external oblique and over the internal oblique muscles and transversalis fascia. The possible development of an "interstitial" hernia is without basis and has never been seen. This particular "onlay graft" (more correctly an intermuscular graft) is much simpler to apply and has resulted in almost no recurrences and side effects. Placing the patch between the two oblique muscles is therefore recommended for open tension-free primary inguinal hernioplasties.

Entities:  

Mesh:

Year:  1995        PMID: 7893098

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  British contributions to modern herniology of the groin.

Authors:  R C Read
Journal:  Hernia       Date:  2004-10-29       Impact factor: 4.739

2.  Aponeurosis instead of prosthetic mesh for inguinal hernia repair: neither physiological nor new.

Authors:  Julian E Losanoff; J Michael Millis
Journal:  Hernia       Date:  2006-03-23       Impact factor: 4.739

3.  Reliable and valid assessment of Lichtenstein hernia repair skills.

Authors:  C G Carlsen; K Lindorff-Larsen; P Funch-Jensen; L Lund; P Charles; L Konge
Journal:  Hernia       Date:  2013-12-03       Impact factor: 4.739

4.  Lichtenstein vs anterior preperitoneal prosthetic mesh placement in open inguinal hernia repair: a prospective, randomized trial.

Authors:  R L Muldoon; K Marchant; D D Johnson; G G Yoder; R C Read; M Hauer-Jensen
Journal:  Hernia       Date:  2003-11-19       Impact factor: 4.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.